POSTRADIOTHERAPY NECK DISSECTION FOR HEAD AND NECK SQUAMOUS CELL CARCINOMA: PATTERN OF PATHOLOGIC RESIDUAL CARCINOMA AND PROGNOSIS

被引:32
作者
Lango, Miriam N. [1 ,2 ]
Andrews, Genevieve A. [2 ]
Ahmad, Sidrah [2 ]
Feigenberg, Steven [3 ]
Tuluc, Madalina [4 ]
Gaughan, John [5 ]
Ridge, John A. [1 ]
机构
[1] Fox Chase Canc Ctr, Dept Surg Oncol, Div Head & Neck Canc, Philadelphia, PA 19111 USA
[2] Temple Univ, Dept Otolaryngol Head & Neck Surg, Philadelphia, PA 19122 USA
[3] Fox Chase Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19111 USA
[4] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA
[5] Temple Univ, Dept Biostat, Philadelphia, PA 19122 USA
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2009年 / 31卷 / 03期
关键词
radiotherapy; neck dissection; squamous cell carcinoma of the head and neck; residual microscopic disease; prognosis; NODE-POSITIVE HEAD; EXTRACAPSULAR SPREAD; OROPHARYNGEAL CANCER; RADIATION-THERAPY; RADIOTHERAPY; CHEMORADIOTHERAPY; METASTASES; CHEMOTHERAPY; DISEASE; CHEMORADIATION;
D O I
10.1002/hed.20976
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. For patients with head and neck cancer who were treated using primary radiotherapeutic approaches, the pattern of pathologic residual carcinoma in the neck dissection specimen and its effect on clinical outcome remains unknown. Methods. Medical records of 65 patients who underwent 71 neck dissections a median 7 weeks after radiotherapy were reviewed. Median follow-up was 33 months. Results. Residual cancer, identified in 28 patients (43%), diminished locoregional control (p = .018), recurrence-free (p = .018), and overall survival (p = .02). Thirteen patients (20%,,) had 2 or more pathologically involved lymph nodes. Nine (13%) involved level V. Four (6%) had pathologic involvement of nodal levels not clinically involved by cancer before treatment. In N2-3 patients with positive pathologic specimens, the presence of these factors diminished recurrence-free survival (p = .01). The outcome of patients with pathologic carcinoma but without such ominous factors approached those with negative pathology. Conclusions. For patients with residual carcinoma in the neck following radiation, the pattern of residual disease is an prognosis effective predictor of recurrence. (C) 2008 Wiley Periodicals, Inc. Head Neck 31: 328-337, 2009
引用
收藏
页码:328 / 337
页数:10
相关论文
共 29 条
[1]   REGIONAL OUTCOME IN OROPHARYNGEAL AND PHARYNGOLARYNGEAL CANCER TREATED WITH HIGH-DOSE PER FRACTION RADIOTHERAPY - ANALYSIS OF NECK DISEASE RESPONSE IN 1646 CASES [J].
BERNIER, J ;
BATAINI, JP .
RADIOTHERAPY AND ONCOLOGY, 1986, 6 (02) :87-103
[2]   Chemoradiation after surgery for high-risk head and neck cancer patients: How strong is the evidence? [J].
Bernier, J ;
Cooper, JS .
ONCOLOGIST, 2005, 10 (03) :215-224
[3]   Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer [J].
Bernier, J ;
Domenge, C ;
Ozsahin, M ;
Matuszewska, K ;
Lefèbvre, JL ;
Greiner, RH ;
Giralt, J ;
Maingon, P ;
Rolland, F ;
Bolla, M ;
Cognetti, F ;
Bourhis, J ;
Kirkpatrick, A ;
van Glabbeke, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19) :1945-1952
[4]  
Boyd TS, 1998, HEAD NECK-J SCI SPEC, V20, P132, DOI 10.1002/(SICI)1097-0347(199803)20:2<132::AID-HED6>3.0.CO
[5]  
2-3
[6]   The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease [J].
Clayman, GL ;
Johnson, CJ ;
Morrison, W ;
Ginsberg, L ;
Lippman, SM .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2001, 127 (02) :135-139
[7]   Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck [J].
Cooper, JS ;
Pajak, TF ;
Forastiere, AA ;
Jacobs, J ;
Campbell, BH ;
Saxman, SB ;
Kish, JA ;
Kim, HE ;
Cmelak, AJ ;
Rotman, M ;
Machtay, M ;
Ensley, JF ;
Chao, KSC ;
Schultz, CJ ;
Lee, N ;
Fu, KK .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19) :1937-1944
[8]   Neck level-specific nodal metastases in oropharyngeal cancer: Is there a role for selective neck dissection after definitive radiation therapy? [J].
Doweck, I ;
Robbins, KT ;
Mendenhall, WM ;
Hinerman, RW ;
Morris, C ;
Amdur, A .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2003, 25 (11) :960-967
[9]   Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer [J].
Goguen, LA ;
Posner, MSR ;
Tishler, RB ;
Wirth, LJ ;
Norris, CM ;
Annino, DJ ;
Sullivan, CA ;
Li, Y ;
Haddad, RI .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2006, 132 (05) :526-531
[10]  
Goodman MD, 1997, AM J SURG, V174, P527